Literature DB >> 23157860

[Awareness rate, treatment rate and control rate of dyslipidemia in Chinese adults, 2010].

Jian-hong Li1, Li-min Wang, Sheng-quan Mi, Mei Zhang, Yi-chong Li, Yong Jiang, Yu Xu, Meng Dai, Lin-hong Wang.   

Abstract

OBJECTIVE: To explore the awareness, treatment and control rates of dyslipidemia among Chinese adults aged over 18 in 2010, and to analyze the prevalent features.
METHODS: 97 409 subjects aged over 18 were recruited from 162 monitoring sites around 31 provinces in China mainland in 2010, applying multi-stage stratified cluster random sampling method. Information about subjects' history of dyslipidemia, treatment and control were collected by face-to-face interview; and each subject's fasting venous blood was drawn in the morning before having food, to test total cholesterol (TC), triglyceride (TG), high density lipoprotein-cholesterol (HDL-C) and low density lipoprotein-cholesterol (LDL-C). In total, 51 818 cases of dyslipidemia ever or now, including 2235 subjects who once suffered from dyslipidemia but had their blood lipid controlled to normal, were screened out. And the awareness, treatment and control rates were calculated by complex weighting.
RESULTS: The awareness rate of dyslipidemia among Chinese adults was 10.93%, while the stratified rates were 6.00%, 16.75% and 18.74% in the groups of subjects aged 18 - 44, 45 - 59 and over 60 years old, respectively (χ² = 1293.02, P < 0.01); 10.32% and 11.71% among males and females, respectively (χ² = 18.67, P < 0.01); 16.59% and 8.17% in groups from urban and rural areas, respectively (χ² = 618.38, P < 0.01); and 12.22%, 11.75% and 8.26% in groups from eastern, central and western China, respectively (χ² = 117.04, P < 0.01). The treatment rate of dyslipidemia was 6.84% among Chinese adults, while the stratified rates were 3.55%, 10.73% and 12.05% in the groups of subjects aged 18 - 44, 45 - 59 and over 60 years old, respectively (χ² = 858.72, P < 0.01); 6.37% and 7.43% among males and females, respectively (χ² = 16.69, P < 0.01); 10.17% and 5.21% in groups from urban and rural areas, respectively (χ² = 327.51, P < 0.01); and 7.33%, 7.52% and 5.41% in groups from eastern, central and western China, respectively (χ² = 50.71, P < 0.01). The control rate of dyslipidemia was 3.53% among total subjects, while whose stratified rates were 1.64%, 5.49% and 6.94% in the groups of subjects aged 18 - 44, 45 - 59 and over 60 years old, respectively (χ² = 554.12, P < 0.01); 2.57% and 4.75% among males and females, respectively (χ² = 131.04, P < 0.01); 5.23% and 2.70% in groups from urban and rural areas, respectively (χ² = 165.13, P < 0.01) ; and 4.21%, 3.89% and 2.17% in groups from eastern, central and western China, respectively (χ² = 91.45, P < 0.01).
CONCLUSION: The awareness, treatment and control rates of dyslipidemia have been comparatively low among Chinese adults, especially among the population who were young, or who were from rural area or western China.

Entities:  

Mesh:

Year:  2012        PMID: 23157860

Source DB:  PubMed          Journal:  Zhonghua Yu Fang Yi Xue Za Zhi        ISSN: 0253-9624


  18 in total

1.  Association of NCOA2 gene polymorphisms with obesity and dyslipidemia in the Chinese Han population.

Authors:  Yuping Lu; Tsadik Ghebreamlak Habtetsion; Yong Li; Huiping Zhang; Yichun Qiao; Mingxi Yu; Yuan Tang; Qing Zhen; Yi Cheng; Yawen Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  An Evaluation on the Effect of Health Education and of Low-Dose Statin in Dyslipidemia among Low-Income Rural Uyghur Adults in Far Western China: A Comprehensive Intervention Study.

Authors:  Jiaolong Ma; Shuxia Guo; Rulin Ma; Jingyu Zhang; Jiaming Liu; Yusong Ding; Mei Zhang; Heng Guo; Jia He; Yizhong Yan; Lati Mu; Shugang Li; Qiang Niu
Journal:  Int J Environ Res Public Health       Date:  2015-09-11       Impact factor: 3.390

3.  Prevalence, awareness, treatment and control of dyslipidemia among adults in northwestern China: the cardiovascular risk survey.

Authors:  Jun-yi Luo; Yi-Tong Ma; Zi-xiang Yu; Yi-Ning Yang; Xiang Xie; Xiang Ma; Fen Liu; Xiao-mei Li; Bang-dang Chen
Journal:  Lipids Health Dis       Date:  2014-01-06       Impact factor: 3.876

4.  Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control.

Authors:  Yuanxiu Huang; Lin Gao; Xiaoping Xie; Seng Chuen Tan
Journal:  Popul Health Metr       Date:  2014-10-28

5.  Association of high-density lipoprotein with development of metabolic syndrome components: a five-year follow-up in adults.

Authors:  Xiangtong Liu; Lixin Tao; Kai Cao; Zhaoping Wang; Dongning Chen; Jin Guo; Huiping Zhu; Xinghua Yang; Youxin Wang; Jingjing Wang; Chao Wang; Long Liu; Xiuhua Guo
Journal:  BMC Public Health       Date:  2015-04-22       Impact factor: 3.295

6.  The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey.

Authors:  Fu-Liang Zhang; Ying-Qi Xing; Yan-Hua Wu; Hao-Yuan Liu; Yun Luo; Ming-Shuo Sun; Zhen-Ni Guo; Yi Yang
Journal:  Lipids Health Dis       Date:  2017-03-23       Impact factor: 3.876

7.  2016 Chinese guidelines for the management of dyslipidemia in adults.

Authors: 
Journal:  J Geriatr Cardiol       Date:  2018-01       Impact factor: 3.327

Review 8.  Outcome Reporting Variability in Trials of Chinese Medicine for Hyperlipidemia: A Systematic Review for Developing a Core Outcome Set.

Authors:  Geng Li; Ruxue Han; Wencong Cao; Zehuai Wen; Xiankun Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-10       Impact factor: 2.629

9.  Dyslipidemia awareness, treatment, control and influence factors among adults in the Jilin province in China: a cross-sectional study.

Authors:  Huan He; Ya-qin Yu; Yong Li; Chang-gui Kou; Bo Li; Yu-chun Tao; Qing Zhen; Chang Wang; Joseph Sam Kanu; Xu-feng Huang; Mei Han; Ya-wen Liu
Journal:  Lipids Health Dis       Date:  2014-08-03       Impact factor: 3.876

10.  Differences in the distribution of risk factors for stroke among the high-risk population in urban and rural areas of Eastern China.

Authors:  Te Mi; Shangwen Sun; Yifeng Du; Shougang Guo; Lin Cong; Mingfeng Cao; Qinjian Sun; Yi Sun; Chuanqiang Qu
Journal:  Brain Behav       Date:  2016-04-07       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.